Epithalon

Epithalon

Research use only. Epithalon (Epitalon) is not FDA-approved. This is educational content, not medical advice.

Description

Epithalon (also written Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) associated with the St. Petersburg Institute of Bioregulation and Gerontology and the work of Professor Vladimir Khavinson. It has been studied for effects on aging-related biomarkers, including telomerase activity and telomere dynamics, largely in cell and animal research and select human studies reported by the originating research groups.

Key claim in the literature: Epithalon has been reported to stimulate telomerase activity in certain cell types under experimental conditions.

Potential Benefits (as studied)

  • Telomerase activation and telomere maintenance signals in cell studies (experimental).
  • Potential modulation of circadian/sleep-related parameters in aging research contexts.
  • Possible immune function changes in aging models.
  • General “geroprotective” signaling effects reported by the originating research groups.

Side Effects

  • Human safety data is limited and heterogeneous.
  • Injection site irritation (if injected).
  • Headache or transient fatigue (anecdotal reports).
  • Allergic reactions are possible with any peptide.

Contraindications / Who Should Avoid

  • Pregnancy/breastfeeding (avoid).
  • Active malignancy or high cancer risk: avoid unless under specialist oversight (telomerase-related concerns).
  • Immunosuppressive therapy or autoimmune conditions: clinician review recommended.
  • Known hypersensitivity.

Dosing Protocols (Research/Reference)

Cycle-based protocol (common community reference)

  • 5–10 mg daily for 10–20 days.
  • Repeat cycle 2–3×/year (often cited in peptide circles).

Reconstitution (lyophilized vial reference)

  • Reconstitute with bacteriostatic water using sterile technique.
  • Example: add 2 mL to a 10 mg vial → 5 mg/mL.
  • At 5 mg/mL, a 10 mg dose = 2.0 mL (may require split injections depending on volume limits).

Practical notes

  • Because cycle doses can be in mg (not mcg), verify vial size and injection volumes.
  • Keep cycles conservative; more is not automatically better.
Risk note: Any intervention tied to telomerase biology should be treated cautiously, especially in people with cancer history.

Stacking Suggestions (Research Context)

  • Often discussed alongside lifestyle anti-aging pillars (sleep, resistance training, metabolic health).
  • If stacking with other “longevity peptides” (e.g., thymic peptides), introduce one variable at a time.

Research Sources (PubMed)

  1. Khavinson VKh et al. Biochemistry (Mosc). 2003. PMID: 12680148
  2. Anisimov VN et al. Mech Ageing Dev. 2001. PMID: 11596260
  3. Khavinson VKh et al. Ontogenez. 2006. PMID: 16913672
  4. Khavinson VKh, et al. Bull Exp Biol Med. 2009. PMID: 20126032
  5. Korkushko OV et al. Adv Gerontol. 2004. PMID: 15632831
  6. Druzhynina NA et al. Bull Exp Biol Med. 2011. PMID: 21436639
Scroll to Top